Antibodies to tgfbeta

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/18 (2006.01)

Patent

CA 2597098

The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF.beta.), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF.beta.1, TGF.beta.2, and TGF.beta.3, so- called "pan-specific" antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).

La présente invention concerne des molécules d'anticorps, en particulier des molécules d'anticorps qui fixent le facteur de croissance transformant bêta (TGF.beta.), et leurs applications. L'invention concerne plus particulièrement des molécules d'anticorps qui fixent et, de préférence, neutralisent, TGF.beta.1, TGF.beta.2 et TGF.beta.3, des molécules d'anticorps dites <= pan-spécifiques >=, et leurs applications. Les modes de réalisation préférés de la présente invention concernent des molécules d'anticorps, à savoir des anticorps totaux (des IgG, tels que IgG1 ou IgG4, par exemple) ou des fragments d'anticorps (scFv, Fab, dAb, par exemple).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies to tgfbeta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to tgfbeta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to tgfbeta will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1848960

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.